PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

PRISM MARKETVIEW PREVIEWS ANTICIPATED FDA DRUG APPROVALS FOR 2024

New York, N.Y., March 25, 2024 - PRISM MarketView - Drug development is an arduous, costly and time-consuming process for the teams involved behind the scenes, and the patients anxiously awaiting breakthroughs in different disease areas. It takes 12 years on average...

Avant Technologies to Build First AI-Focused Data Center in Milwaukee

Avant Technologies to Build First AI-Focused Data Center in Milwaukee

LAS VEGAS, NEVADA, March 25, 2024 – Avant Technologies, Inc. (OTCQB: AVAI) (“Avant” or the “Company”), an artificial intelligence technology (AI) company specializing in creating and developing innovative and advanced AI infrastructure solutions, today announced plans...

Nutra Pharma Corp. Reaches Settlement with SEC

Nutra Pharma Corp. Reaches Settlement with SEC

Nutra Pharma Corp. has reached a bifurcated settlement with the SEC along with its CEO and a Consultant to the company Coral Springs, Florida, March 22, 2024 - Nutra Pharma Corporation (OTC: NPHC), (“Nutra Pharma” or the “Company”) reached a settlement with the U.S....